Contributor Page
Wilson Elser Moskowitz Edelman & Dicker LLP
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 914 323 7000
Fax: +1 914 323 7001
1133 Westchester Avenue White Plains
New York
NY 10604
United States
By Stephen Brown
A Connecticut federal court judge provided clarification on medical marijuana use under the Connecticut Palliative Use of Marijuana Act (PUMA) in Noffsinger v. SSC Niantic Operating Company LLC.
By Sean Maraynes
Advances in maternal fetal medicine and neonatology have dramatically increased survival rates for extremely premature infants, defined as infants born at fewer than 28 weeks gestation.
By Neil M. Willner
The New York State Department of Health's two-year report on the progress of its medical marijuana program revealed a 1,124% increase in certified patients registered under the program.
By Ian Stewart, James Kloss, Neil M. Willner
Public interest in the potential health benefits of CBD (cannabidiol) is responsible for a whole new market segment of health and wellness foods and supplements that features CBD as an ingredient.
By Michael P. Manfredi
If you have spent any time in Los Angeles or New York City recently, you may have noticed adults riding two-wheeled electric scooters ...
By E. Paul Dougherty Jr.
By now, followers of California's Proposition 65 are well aware of the August 30, 2018, changes.
By Kara Thorvaldsen
A federal jury recently found a Colorado cannabis cultivator not liable for violating the federal Racketeer Influenced and Corrupt Organizations (RICO) statute following a three-day jury trial.
By Bonnie Ackerman
Physicians typically recall, with stunning clarity, the moment a patient's treatment went wrong.
By David H. Potter
Data breaches and cyberattacks are becoming more prevalent and law firms have quickly become attractive targets for hackers due to the sensitive and privileged information firms collect.
By Sean McDonough, Jacqueline M. Bertelsen
After more than five years of uncertainty, the Florida Supreme Court's opinion in DeLisle v. Crane finally settled the debate over the standard for determining the admissibility...
By Neil M. Willner
On September 28, 2018, the Drug Enforcement Administration (DEA) took the long-awaited step of rescheduling Epidiolex®
By Rosario Vignali
The discovery phase in your products liability lawsuit has been completed and it's time to decide the next course of action before proceeding to trial.
By Ian Stewart, Robert Cornish Jr.
U.S. Customs and Border Protection clarified on October 9, 2018, that Canadians who work in Canada's legal cannabis industry may enter the United States for non-work-related reasons without negative consequences.
By Rosario Vignali
The discovery phase in your products liability lawsuit has been completed and it's time to decide the next course of action before proceeding to trial.
By Robert Cornish Jr., Chandler R. Finley, Jordan Montet, Ian Stewart
Canada's nascent cannabis industry has experienced revolutionary growth over the past two years, as dozens of licensed producers ...
Contributor's Topics
More...